Please assess the completion status of the following clinical trial:

Trial Title: Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic Cancer

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Unresectable pancreatic adenocarcinoma~* Weight loss of greater than 5% in the previous 6 months~* Life expectancy of greater than 3 months and a Karnofsky performance score of 60 or more.~* Non-smokers~Exclusion Criteria:~* Chemotherapy other than gemcitabine~* Radiotherapy, or surgical treatment in the previous month~* Consumption of dietary supplements or medications such as steroids that could affect metabolism.~* Presence of ascites~* Liver function test \> 2 standard deviation of upper limit~* Chronic or acute renal insufficiency~* Severe anemia with hemoglobin\<10~* Uncontrolled pain~* Uncontrolled nausea and vomiting~* Participation in a therapeutic research study within 30 days of baseline~* Diet restrictions including vegetarianism and veganism~* Allergy or intolerance to fish and/or fish oil

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Diet + Nutrawell Powder with Fish Oil (Type: ACTIVE_COMPARATOR): Subjects will be evaluated by a registered dietitian with a diet prescription (55% carbohydrate, 30% fat and 15% protein) including Nutrawell powder with fish oil.
- Dietary Intervention Only (Type: ACTIVE_COMPARATOR): Subjects will be evaluated by a registered dietitian with a diet prescription (55% carbohydrate, 30% fat and 15% protein) not including servings of Nutrawell powder with fish oil.

Based on this trial design, predict the completion outcome and termination type (if applicable).